In order to respond to the increase in the number of patients with COVID-19, it was pointed out that the prescription rate of treatments such as Paxlovid should be raised more than now, while continuing to maintain an environment where prescriptions are quickly prescribed. It was also suggested that the fast track of the COVID-19 high-risk oral drug prescription currently prepared by the government should be repeatedly checked, and the fast track system should not be predicted to continue to be sustainable. On the 17th, Jeong Ki-seok, chairman of the National Advisory Committee on Infectious Disease Crisis Response, made this announcement at a regular briefing on COVID-19. Chairman Chung Ki-seok positively assessed th